Read on Twitter
Ex-Google CEO Eric Schmidt in 2010, “The average American doesn’t realize how much of the laws are written by lobbyists.”
Schmidt increased Google’s lobbying budget 23,650% during his tenure from roughly 2003 to 2020.
More about #SchmidtInc🧵:
Schmidt increased Google’s lobbying budget 23,650% during his tenure from roughly 2003 to 2020.
More about #SchmidtInc🧵:
https://twitter.com/BullMooseProj/status/1669339028146237440
Schmidt invested in Astra, a rocket startup, which was selected by the Air Force AFWERX program for its Rocket 5.0 program.
Schmidt was a proponent of AFWERX’s creation in 2018 and promoted the program through testimony to Congress and as Chair of the Defense Innovation Board.
Schmidt was a proponent of AFWERX’s creation in 2018 and promoted the program through testimony to Congress and as Chair of the Defense Innovation Board.
Eric Lander, Biden’s former OSTP chief, was connected with Schmidt through the Broad Institute.
After Lander was nominated, Schmidt contributed $150 million to the initiative. Inside OSTP, Lander hired officials whose salaries were paid by Schmidt Futures.
After Lander was nominated, Schmidt contributed $150 million to the initiative. Inside OSTP, Lander hired officials whose salaries were paid by Schmidt Futures.
OSTP general counsel said that doing so raised "significant ethical concerns."
More than a dozen officials in the 140-person White House office have been associates of Schmidt’s, including some current and former Schmidt employees, according to @politico.
More than a dozen officials in the 140-person White House office have been associates of Schmidt’s, including some current and former Schmidt employees, according to @politico.
In August 2021, Lander released an interagency memo prioritizing biotech for national security. That same month, Schmidt incorporated a new fund which has invested in at least 4 biotech companies.
In 2023, Scmidt joined the National Security Commission on Emerging Biotechnology.
In 2023, Scmidt joined the National Security Commission on Emerging Biotechnology.
It's clear that Eric Schmidt's involvement in key government offices and programs conflict with his business dealings and investments. What have we not seen or heard about?
We need accountability -- and more stringent ethics rules for advisory commission appointees.
We need accountability -- and more stringent ethics rules for advisory commission appointees.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
